An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Experimental Drug Acquiring Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these profiles directly for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a robust trade exists on Telegram, where groups with numerous of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors market the substance there before directing buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Voice Worries
However, doctors and chemists have warned that the sale of what is still an unlicensed drug in the UK is worrisome and could lead to users administering substances of unknown origin.
Several experts stated the demand for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and consumer laws, risking penalties, prosecution or imprisonment.
Service Response and Content Elimination
Based on TikTok, the service has taken down violative content and prohibited related keywords and search suggestions. The company said it was committed to maintaining the service safe and investing in strengthening enforcement strategies.
Online Trading Activities
Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, filled with photos of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within moments of entering one group, a vendor shared contact information, where most purchases take place. The seller sent an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.
Item Details and Costs
Inside these groups, messages show black plastic packages with postal service stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for Telegram stated it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting substances they can’t verify. Although the research behind this drug is sound, these digital products may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of an online medical service connected the surge in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.
Her team has already encountered patients harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet approved … may subject users to potentially serious health risks”.
